Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease
Aims A dose–response meta‐analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. Methods A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose–respon...
Saved in:
| Published in | Geriatrics & gerontology international Vol. 14; no. 2; pp. 430 - 439 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
Blackwell Publishing Ltd
01.04.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Aims
A dose–response meta‐analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.
Methods
A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose–response relationship was assessed by restricted cubic spline.
Results
A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included. A non‐linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking‐adjusted relative risk: 0.72, 95% confidence interval 0.65–0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking‐adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia.
Conclusions
A linear dose‐relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall. Further studies are required to confirm the findings. Geriatr Gerontol Int 2014; 14: 430–439. |
|---|---|
| AbstractList | Aims
A dose–response meta‐analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.
Methods
A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose–response relationship was assessed by restricted cubic spline.
Results
A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included. A non‐linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking‐adjusted relative risk: 0.72, 95% confidence interval 0.65–0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking‐adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia.
Conclusions
A linear dose‐relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall. Further studies are required to confirm the findings. Geriatr Gerontol Int 2014; 14: 430–439. A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.AIMSA dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose-response relationship was assessed by restricted cubic spline.METHODSA comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose-response relationship was assessed by restricted cubic spline.A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included. A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia.RESULTSA total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included. A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia.A linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall. Further studies are required to confirm the findings.CONCLUSIONSA linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall. Further studies are required to confirm the findings. A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose-response relationship was assessed by restricted cubic spline. A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included. A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia. A linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall. Further studies are required to confirm the findings. Geriatr Gerontol Int 2014; 14: 430-439. Aims A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. Methods A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose-response relationship was assessed by restricted cubic spline. Results A total of 13 articles involving 901764 participants for coffee, eight articles involving 344895 participants for tea and seven articles involving 492724 participants for caffeine were included. A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia. Conclusions A linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3cups/day for coffee consumption overall. Further studies are required to confirm the findings. Geriatr Gerontol Int 2014; 14: 430-439. A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. A comprehensive search was carried out to identify eligible studies. The fixed or random effect model was used based on heterogeneity test. The dose-response relationship was assessed by restricted cubic spline. A total of 13 articles involving 901 764 participants for coffee, eight articles involving 344 895 participants for tea and seven articles involving 492 724 participants for caffeine were included. A non-linear relationship was found between coffee consumption and PD risk overall, and the strength of protection reached the maximum at approximately 3 cups/day (smoking-adjusted relative risk: 0.72, 95% confidence interval 0.65-0.81). A linear relationship was found between tea and caffeine consumption, and PD risk overall, and the smoking-adjusted risk of PD decreased by 26% and 17% for every two cups/day and 200 mg/day increments, respectively. The association of coffee and tea consumption with PD risk was stronger for men than that for women, and the association of caffeine consumption with PD risk was stronger for ever users of hormones than that for never users of hormones among postmenopausal women. The aforementioned associations were weaker for USA relative to Europe or Asia. A linear dose-relationship for decreased PD risk with tea and caffeine consumption was found, whereas the strength of protection reached a maximum at approximately 3 cups/day for coffee consumption overall. Further studies are required to confirm the findings. |
| Author | Qi, Hui Li, Shixue |
| Author_xml | – sequence: 1 givenname: Hui surname: Qi fullname: Qi, Hui organization: Department of Social Medicine and Health Administration, School of Public Health, Shandong University, Jinan, China – sequence: 2 givenname: Shixue surname: Li fullname: Li, Shixue email: sdlishixue@126.com organization: Department of Social Medicine and Health Administration, School of Public Health, Shandong University, Jinan, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23879665$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtP3TAQhS0E4tUu-gcqS13AooE4dvxY8ryAUFskqnZnOcmEGhL7kkkE99_X3Assuqo3M9Z8Z6Q5Z4eshxiAkE8sP2DpHd7d-QNWsIKvkW0mhMry0oj1ZS8yVmq5RXYQ7_OcKcPYJtkquFZGynKbNKcRIRsA5zEg0B5Gl7ngugV6pDHQOrYtwFc6gqMuNLR26e8DpEHAqZ-PPkFPfvxDB48PNLb0hxsefMAY9pA2HsEhfCAbresQPr7WXfLz_Oz25CK7_j67PDm6zjxXgme8YnWhnDCVZLpiRWVA1Y2BSjaqqqVqFaRaNxJaY7TSIItSa8l1U6iWp_N3yf5q73yIjxPgaHuPNXSdCxAntKwsBDdCa_EfKOO5MMzwhH75B72P05A8SpSSORNSipeFn1-pqeqhsfPB925Y2DerE3C4Ap58B4v3OcvtS4Y2ZWiXGdrZ7HLZJEW2Ungc4fldkfy1UnFV2l_fZrY8vrn6fSO4veV_AYhfnfw |
| ContentType | Journal Article |
| Copyright | 2013 Japan Geriatrics Society 2013 Japan Geriatrics Society. Copyright © 2014 Japan Geriatrics Society |
| Copyright_xml | – notice: 2013 Japan Geriatrics Society – notice: 2013 Japan Geriatrics Society. – notice: Copyright © 2014 Japan Geriatrics Society |
| DBID | BSCLL CGR CUY CVF ECM EIF NPM K9. 7X8 7U1 C1K |
| DOI | 10.1111/ggi.12123 |
| DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Risk Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Risk Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE - Academic Risk Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1447-0594 |
| EndPage | 439 |
| ExternalDocumentID | 3933198071 23879665 GGI12123 ark_67375_WNG_5BQJXQ43_T |
| Genre | article Meta-Analysis Journal Article |
| GeographicLocations | Asia USA Europe |
| GeographicLocations_xml | – name: USA – name: Europe – name: Asia |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 29H 31~ 33P 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACHQT ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ CGR CUY CVF ECM EIF NPM AAMMB AEFGJ AGQPQ AGXDD AGYGG AIDQK AIDYY K9. 7X8 7U1 C1K |
| ID | FETCH-LOGICAL-i3743-3b1c27a49b618b12b9e7cd9eb6d7bc67f7e7bccd6ef99878e62588638d27f3123 |
| IEDL.DBID | DR2 |
| ISSN | 1444-1586 1447-0594 |
| IngestDate | Fri Jul 11 13:04:44 EDT 2025 Fri Jul 11 06:37:08 EDT 2025 Fri Jul 25 07:32:13 EDT 2025 Wed Feb 19 02:06:40 EST 2025 Wed Jan 22 17:08:22 EST 2025 Wed Oct 30 09:50:44 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | dose-response meta-analysis tea caffeine Parkinson's disease coffee |
| Language | English |
| License | 2013 Japan Geriatrics Society. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-i3743-3b1c27a49b618b12b9e7cd9eb6d7bc67f7e7bccd6ef99878e62588638d27f3123 |
| Notes | ark:/67375/WNG-5BQJXQ43-T ArticleID:GGI12123 istex:59BBB612467296BE9085C70E0571B67E0E78C607 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 23879665 |
| PQID | 1760146644 |
| PQPubID | 29143 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1524394884 proquest_miscellaneous_1513049193 proquest_journals_1760146644 pubmed_primary_23879665 wiley_primary_10_1111_ggi_12123_GGI12123 istex_primary_ark_67375_WNG_5BQJXQ43_T |
| PublicationCentury | 2000 |
| PublicationDate | April 2014 |
| PublicationDateYYYYMMDD | 2014-04-01 |
| PublicationDate_xml | – month: 04 year: 2014 text: April 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan – name: Richmond |
| PublicationTitle | Geriatrics & gerontology international |
| PublicationTitleAlternate | Geriatrics & Gerontology International |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Prediger RD. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis 2010; 20 (Suppl 1): S205-S220. Benedetti MD, Bower JH, Maraganore DM et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000; 55: 1350-1358. Liu R, Guo X, Park Y et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 2012; 175: 1200-1207. Palacios N, Gao X, McCullough ML et al. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord 2012; 27: 1276-1282. Tanaka K, Miyake Y, Fukushima W et al. Intake of Japanese and Chinese teas reduces risk of Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 446-450. Xu K, Xu YH, Chen JF, Schwarzschild MA. Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett 2002; 322: 13-16. Ragonese P, Salemi G, Morgante L et al. A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology 2003; 22: 297-304. Shulman LM. Is there a connection between estrogen and Parkinson's disease? Parkinsonism Relat Disord 2002; 8: 289-295. Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia 2012; doi: 10/1016/j.nrl.2012.04.001. Trinh K, Andrews L, Krause J et al. Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism. J Neurosci 2010; 30: 5525-5532. Paganini-Hill A. Risk factors for parkinson's disease: the leisure world cohort study. Neuroepidemiology 2001; 20: 118-124. Nettleton JA, Follis JL, Schabath MB. Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009; 169: 1445-1453. Ritz B, Ascherio A, Checkoway H et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007; 64: 990-997. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 2010; 29: 1282-1297. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005; 57: 27-33. Ross GW, Abbott RD, Petrovitch H et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000; 283: 2674-2679. Spiller MA. The chemical components of coffee. Prog Clin Biol Res 1984; 158: 91-147. Tan LC, Koh WP, Yuan JM et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 2008; 167: 553-560. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294: 97-104. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006; 6: 40-57. Schwarzschild MA. Caffeine in Parkinson disease: better for cruise control than snooze patrol? Neurology 2012; 79: 616-618. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, Jr, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002; 155: 732-738. Xu K, Xu YH, Chen JF, Schwarzschild MA. Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 2010; 167: 475-481. Park M, Ross GW, Petrovitch H et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology 2005; 64: 1047-1051. Pollock BG, Wylie M, Stack JA et al. Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 1999; 39: 936-940. Zhang ZX, Roman GC, Hong Z et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 2005; 365: 595-597. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010; 29: 1037-1057. Ascherio A, Zhang SM, Hernan MA et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001; 50: 56-63. Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 2007; 22: 2242-2248. Fall PA, Fredrikson M, Axelson O, Granerus AK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999; 14: 28-37. Grant WB. The role of milk protein in increasing risk of Parkinson's disease. Eur J Epidemiol 2013; 28: 357. Ascherio A, Weisskopf MG, O'Reilly EJ et al. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 2004; 160: 977-984. Tan EK, Chua E, Fook-Chong SM et al. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogenet Genomics 2007; 17: 1001-1005. Saaksjarvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Mannisto S. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr 2008; 62: 908-915. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73. Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol 2013; 28: 67-77. 2007; 17 2001; 50 2005; 294 2013; 28 2012 2002; 155 2010; 167 2004; 160 2002; 8 2005; 64 2006; 6 2008; 167 2011; 17 2012; 79 2001; 20 2012; 175 2010; 20 2003; 327 1984; 158 2005; 365 2010; 29 2002; 322 1999; 39 2000; 55 1999; 14 2000; 283 2012; 27 2007; 64 2008; 62 2007; 22 2010; 30 2009; 169 2003; 22 2005; 57 |
| References_xml | – reference: Trinh K, Andrews L, Krause J et al. Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism. J Neurosci 2010; 30: 5525-5532. – reference: Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 2007; 22: 2242-2248. – reference: Pollock BG, Wylie M, Stack JA et al. Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 1999; 39: 936-940. – reference: Paganini-Hill A. Risk factors for parkinson's disease: the leisure world cohort study. Neuroepidemiology 2001; 20: 118-124. – reference: Shulman LM. Is there a connection between estrogen and Parkinson's disease? Parkinsonism Relat Disord 2002; 8: 289-295. – reference: Tan LC, Koh WP, Yuan JM et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 2008; 167: 553-560. – reference: Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005; 57: 27-33. – reference: van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294: 97-104. – reference: Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, Jr, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002; 155: 732-738. – reference: Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol 2013; 28: 67-77. – reference: Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 2010; 29: 1282-1297. – reference: Tan EK, Chua E, Fook-Chong SM et al. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogenet Genomics 2007; 17: 1001-1005. – reference: Ross GW, Abbott RD, Petrovitch H et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000; 283: 2674-2679. – reference: Spiller MA. The chemical components of coffee. Prog Clin Biol Res 1984; 158: 91-147. – reference: Palacios N, Gao X, McCullough ML et al. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord 2012; 27: 1276-1282. – reference: Prediger RD. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis 2010; 20 (Suppl 1): S205-S220. – reference: Xu K, Xu YH, Chen JF, Schwarzschild MA. Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 2010; 167: 475-481. – reference: Grant WB. The role of milk protein in increasing risk of Parkinson's disease. Eur J Epidemiol 2013; 28: 357. – reference: Nettleton JA, Follis JL, Schabath MB. Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009; 169: 1445-1453. – reference: Liu R, Guo X, Park Y et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 2012; 175: 1200-1207. – reference: Ascherio A, Zhang SM, Hernan MA et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001; 50: 56-63. – reference: Saaksjarvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Mannisto S. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr 2008; 62: 908-915. – reference: Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010; 29: 1037-1057. – reference: Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. – reference: Schwarzschild MA. Caffeine in Parkinson disease: better for cruise control than snooze patrol? Neurology 2012; 79: 616-618. – reference: Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006; 6: 40-57. – reference: Zhang ZX, Roman GC, Hong Z et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 2005; 365: 595-597. – reference: Fall PA, Fredrikson M, Axelson O, Granerus AK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999; 14: 28-37. – reference: Ritz B, Ascherio A, Checkoway H et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007; 64: 990-997. – reference: Park M, Ross GW, Petrovitch H et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology 2005; 64: 1047-1051. – reference: Xu K, Xu YH, Chen JF, Schwarzschild MA. Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett 2002; 322: 13-16. – reference: Tanaka K, Miyake Y, Fukushima W et al. Intake of Japanese and Chinese teas reduces risk of Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 446-450. – reference: Benedetti MD, Bower JH, Maraganore DM et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000; 55: 1350-1358. – reference: Ragonese P, Salemi G, Morgante L et al. A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology 2003; 22: 297-304. – reference: Ascherio A, Weisskopf MG, O'Reilly EJ et al. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 2004; 160: 977-984. – reference: Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73. – reference: Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia 2012; doi: 10/1016/j.nrl.2012.04.001. – volume: 64 start-page: 1047 year: 2005 end-page: 1051 article-title: Consumption of milk and calcium in midlife and the future risk of Parkinson disease publication-title: Neurology – volume: 365 start-page: 595 year: 2005 end-page: 597 article-title: Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai publication-title: Lancet – volume: 8 start-page: 289 year: 2002 end-page: 295 article-title: Is there a connection between estrogen and Parkinson's disease? publication-title: Parkinsonism Relat Disord – volume: 22 start-page: 2242 year: 2007 end-page: 2248 article-title: Coffee and tea consumption and the risk of Parkinson's disease publication-title: Mov Disord – volume: 169 start-page: 1445 year: 2009 end-page: 1453 article-title: Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study publication-title: Am J Epidemiol – volume: 55 start-page: 1350 year: 2000 end-page: 1358 article-title: Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case‐control study publication-title: Neurology – volume: 22 start-page: 297 year: 2003 end-page: 304 article-title: A case‐control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease publication-title: Neuroepidemiology – volume: 160 start-page: 977 year: 2004 end-page: 984 article-title: Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen publication-title: Am J Epidemiol – volume: 322 start-page: 13 year: 2002 end-page: 16 article-title: Caffeine's neuroprotection against 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice publication-title: Neurosci Lett – volume: 17 start-page: 446 year: 2011 end-page: 450 article-title: Intake of Japanese and Chinese teas reduces risk of Parkinson's disease publication-title: Parkinsonism Relat Disord – volume: 283 start-page: 2674 year: 2000 end-page: 2679 article-title: Association of coffee and caffeine intake with the risk of Parkinson disease publication-title: JAMA – volume: 64 start-page: 990 year: 2007 end-page: 997 article-title: Pooled analysis of tobacco use and risk of Parkinson disease publication-title: Arch Neurol – volume: 294 start-page: 97 year: 2005 end-page: 104 article-title: Coffee consumption and risk of type 2 diabetes: a systematic review publication-title: JAMA – volume: 50 start-page: 56 year: 2001 end-page: 63 article-title: Prospective study of caffeine consumption and risk of Parkinson's disease in men and women publication-title: Ann Neurol – volume: 79 start-page: 616 year: 2012 end-page: 618 article-title: Caffeine in Parkinson disease: better for cruise control than snooze patrol? publication-title: Neurology – volume: 175 start-page: 1200 year: 2012 end-page: 1207 article-title: Caffeine intake, smoking, and risk of Parkinson disease in men and women publication-title: Am J Epidemiol – volume: 158 start-page: 91 year: 1984 end-page: 147 article-title: The chemical components of coffee publication-title: Prog Clin Biol Res – volume: 29 start-page: 1282 year: 2010 end-page: 1297 article-title: Extending DerSimonian and Laird's methodology to perform multivariate random effects meta‐analyses publication-title: Stat Med – volume: 27 start-page: 1276 year: 2012 end-page: 1282 article-title: Caffeine and risk of Parkinson's disease in a large cohort of men and women publication-title: Mov Disord – volume: 30 start-page: 5525 year: 2010 end-page: 5532 article-title: Decaffeinated coffee and nicotine‐free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2‐dependent mechanism publication-title: J Neurosci – volume: 62 start-page: 908 year: 2008 end-page: 915 article-title: Prospective study of coffee consumption and risk of Parkinson's disease publication-title: Eur J Clin Nutr – year: 2012 article-title: Parkinson disease and Alzheimer disease: environmental risk factors publication-title: Neurologia – volume: 175 start-page: 66 year: 2012 end-page: 73 article-title: Meta‐analysis for linear and nonlinear dose‐response relations: examples, an evaluation of approximations, and software publication-title: Am J Epidemiol – volume: 20 start-page: S205 year: 2010 end-page: S220 article-title: Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non‐motor symptoms publication-title: J Alzheimers Dis – volume: 327 start-page: 557 year: 2003 end-page: 560 article-title: Measuring inconsistency in meta‐analyses publication-title: BMJ – volume: 155 start-page: 732 year: 2002 end-page: 738 article-title: Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake publication-title: Am J Epidemiol – volume: 167 start-page: 553 year: 2008 end-page: 560 article-title: Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study publication-title: Am J Epidemiol – volume: 167 start-page: 475 year: 2010 end-page: 481 article-title: Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease publication-title: Neuroscience – volume: 17 start-page: 1001 year: 2007 end-page: 1005 article-title: Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers publication-title: Pharmacogenet Genomics – volume: 20 start-page: 118 year: 2001 end-page: 124 article-title: Risk factors for parkinson's disease: the leisure world cohort study publication-title: Neuroepidemiology – volume: 29 start-page: 1037 year: 2010 end-page: 1057 article-title: Dose‐response analyses using restricted cubic spline functions in public health research publication-title: Stat Med – volume: 57 start-page: 27 year: 2005 end-page: 33 article-title: Risk and protective factors for Parkinson's disease: a study in Swedish twins publication-title: Ann Neurol – volume: 28 start-page: 67 year: 2013 end-page: 77 article-title: Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece publication-title: Eur J Epidemiol – volume: 39 start-page: 936 year: 1999 end-page: 940 article-title: Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women publication-title: J Clin Pharmacol – volume: 6 start-page: 40 year: 2006 end-page: 57 article-title: Generalized least squares for trend estimation of summarized dose–response data publication-title: Stata J – volume: 14 start-page: 28 year: 1999 end-page: 37 article-title: Nutritional and occupational factors influencing the risk of Parkinson's disease: a case‐control study in southeastern Sweden publication-title: Mov Disord – volume: 28 start-page: 357 year: 2013 article-title: The role of milk protein in increasing risk of Parkinson's disease publication-title: Eur J Epidemiol |
| SSID | ssj0017911 |
| Score | 2.418084 |
| SecondaryResourceType | review_article |
| Snippet | Aims
A dose–response meta‐analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.
Methods
A comprehensive... A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. A comprehensive search was... Aims A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. Methods A comprehensive... A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption.AIMSA dose-response meta-analysis... A dose-response meta-analysis was carried out between Parkinson's disease (PD) risk, and coffee, tea and caffeine consumption. A comprehensive search was... |
| SourceID | proquest pubmed wiley istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 430 |
| SubjectTerms | Aged Caffeine Caffeine - administration & dosage Caffeine - adverse effects Coffee Coffee - adverse effects dose-response meta-analysis Dose-Response Relationship, Drug Female Humans Male Meta-analysis Parkinson Disease, Secondary - chemically induced Parkinson Disease, Secondary - epidemiology Parkinson's disease Risk factors tea Tea - adverse effects |
| Title | Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease |
| URI | https://api.istex.fr/ark:/67375/WNG-5BQJXQ43-T/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fggi.12123 https://www.ncbi.nlm.nih.gov/pubmed/23879665 https://www.proquest.com/docview/1760146644 https://www.proquest.com/docview/1513049193 https://www.proquest.com/docview/1524394884 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB5CDqGX9D_ddltUCG0PcbC9smXTU5s0mwQSSEnIHgrCkkebEGKH7C6EnvYRCn3DPElnZK9pQwmlJ_9INpJHI32jmfkMsE6LQpyHYRE4F8pAOlYpuhGkViEveTZF3tA_OEx3T-T-KBktwcdFLkzDD9FtuLFm-PmaFbwwk9-UfDw-Z2qEmJk-OVaLAdHXjjqKWTe9sSWlDKIkS1tWIY7i6Z4kQMrf8uZv6PJPsOpXm52H8G3RzibI5GJzNjWb9vsdCsf_7MgjWG1RqPjUDJvHsITVE1g5aP3sT-Fsu57g7fzndRNBi-ISp8Xt_EfRUpiIuhK2dg5xQ9AoEUVVClvQNT1NBZzV6aciwdu8gsPXRe0EZ1j7ZLP3E9E6hp7Byc6X463doP0nQ3A-YDbTgYlsrAqZmzTKTBSbHJUtczRpqYxNlVNIR1um6MiQUxmSfZVlpORlrNyAOvkclqu6whcgSrKcXGyNYVCWYJiXJDPpojBTLpboevDOS0dfNbwbmhrJYWgq0aeHQ518PtofHcmBPu5BfyE-3WrgREcc7MPc-bIHb7ti0h12iBQV1jOqk0TsZSQMe1-dmJOHs4zes9YMja5BBHcUmYtJDz54AXcFC8uKRKu9aPVwuOdPXv571VfwgNBZGybUh-Xp9QxfEwKamjd-qP8CEwMBoA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL2qigRseD8GChiJ14JUiceJkwULYOjMtJ2RiqZidiZ27LaqSFBnRjxW_QQkfoNf4Sf6JdzrZCJACLHpgtU87Ik8ybnX59r3HgM8wEmBZ2GYB86FIhCOTAq_CBIjLU15JrG0oD8aJ4NdsTmNpyvwbVkLU-tDtAtuZBneX5OB04L0T1a-t3dA2gh8eXT1lv30AQO22bNhD5_uQ843Xk1eDoLmTIHgoEtqnF0dGS5zkekkSnXEdWalKTKrk0Jqk0gnLb6aIrEOAxGZWowP0hRBWnDpuhHJHKDDP0MniJNSf-91K1ZFOp8-vBNCBFGcJo2OEeUNtUNFCkxP7-Of-Oyv9NjPbxsX4fvyztRpLYfri7leN59_E438X27dJbjQEG32vLaMy7BiyytwdtSkElyF_V41syfHX4_qJGHL3tl5fnL8JW9UWlhVMlM5Z-1ThobA8rJgJsfP-GtsoMJV720ZrWQzytBnlWNURO7r6R7PWLP3dQ12T-V_XofVsirtTWAFBoeOG62Jd8Y2zAoEiXBRmErHhXUdeOThoN7X0iIKB0mZdjJWb8Z9Fb_Y2ZzuiK6adGBtiRfVOJmZiiifiY4HEB243zaje6A9n7y01QL7xBFtpCJN_1sfTvXRaYrXuVFjsR0QMjqJEXHcgSceUW3DMnhEKCkPJdXvD_2bW__e9R6cG0xG22p7ON66DeeRjDZZUWuwOj9a2DtI-Ob6rrczBm9PG50_AGf_YAk |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL2qilSx4f0YKGAkXgtSJR4nThYsgGGm09IRRa06OxM7dqkQSdWZEY9VPwGJz-BX-Ip-Cfc6DwFCiE0XrOZhT-RJzr0-1773GOAeTgo8C8M8cC4UgXBkUvhFkBhpacoziaUF_a1Jsr4rNqbxdAm-tbUwtT5Et-BGluH9NRn4YeF-MvL9_QOSRuDtydWb9tMHjNdmT8YDfLj3OR--2Hm-HjRHCgQHfRLj7OvIcJmLTCdRqiOuMytNkVmdFFKbRDpp8dUUiXUYh8jUYniQpojRgkvXj0jlAP39GZGEGZ0TMXjdaVWRzKeP7oQQQRSnSSNjRGlD3VCRAdPD-_gnOvsrO_bT2_A8fG9vTJ3V8m5tMddr5vNvmpH_yZ27AOcams2e1nZxEZZseQlWtppEgsvwdlDN7Mnx16M6Rdiy93aenxx_yRuNFlaVzFTOWfuYoRmwvCyYyfEz_hobqGzV-1pG69iM8vNZ5RiVkPtquocz1ux8XYHdU_mfV2G5rEp7HViBoaHjRmtinbENswIxIlwUptJxYV0PHng0qMNaWEThICnPTsZqbzJS8bPtjem26KudHqy2cFGNi5mpiLKZ6HAA0YO7XTM6B9rxyUtbLbBPHNE2KpL0v_XhVB2dpnidazUUuwEhn5MYD8c9eOQB1TW0oSNCSXkoqdFo7N_c-Peud2Dl1WCoXo4nmzfhLDLRJiVqFZbnRwt7C9neXN_2VsbgzWmD8wfVDF64 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dose-response+meta-analysis+on+coffee%2C+tea+and+caffeine+consumption+with+risk+of+Parkinson%27s+disease&rft.jtitle=Geriatrics+%26+gerontology+international&rft.au=Qi%2C+Hui&rft.au=Li%2C+Shixue&rft.date=2014-04-01&rft.eissn=1447-0594&rft.volume=14&rft.issue=2&rft.spage=430&rft_id=info:doi/10.1111%2Fggi.12123&rft_id=info%3Apmid%2F23879665&rft.externalDocID=23879665 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1444-1586&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1444-1586&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1444-1586&client=summon |